Quinazoline derivatives as SRC tyrosine kinase inhibitors

Saved in:
Bibliographic Details
Main Author PLE PATRICK
Format Patent
LanguageChinese
English
Published 12.12.2007
Subjects
Online AccessGet full text

Cover

Loading…
Author PLE PATRICK
Author_xml – fullname: PLE PATRICK
BookMark eNrjYmDJy89L5WSwDCzNzEusys_JzEtVSEktyixLLMksSy1WSCxWCA5yViipLMovBsllA5UVpypk5mVkJmWW5BcV8zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwMDY1MTI3MLZ2djohQBANKaMUo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN100354278CC
GroupedDBID EVB
ID FETCH-epo_espacenet_CN100354278CC3
IEDL.DBID EVB
IngestDate Fri Jul 19 16:07:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN100354278CC3
Notes Application Number: CN20038108194
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071212&DB=EPODOC&CC=CN&NR=100354278C
ParticipantIDs epo_espacenet_CN100354278CC
PublicationCentury 2000
PublicationDate 20071212
PublicationDateYYYYMMDD 2007-12-12
PublicationDate_xml – month: 12
  year: 2007
  text: 20071212
  day: 12
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies ASTRAZENECA AB
RelatedCompanies_xml – name: ASTRAZENECA AB
Score 2.793898
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Quinazoline derivatives as SRC tyrosine kinase inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071212&DB=EPODOC&locale=&CC=CN&NR=100354278C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOpYj0rdivLN3DEJZ2DMFuzil7G02bsip0w3aK--u9hNX5tLeQhCMJubt83P1-AHdmwl2aUmLYTkoNCahktG07NVoi4olLiBCpCpANW_1X93FCJjV4r3JhFE7otwJHRI2KUd9LZa8Xm0csX8VWFvc8w6r5Q2_c8fXqdkwtNMW63-0Ew4E_YDpjHRbq4QjPuqZDJK0E24FdeYyWOPvBW1dmpSz-u5TeEewNUVpeHkNtNWvAAauY1xqw_7T-8MbiWveKE2g_L7M8WkmSHaEluHG-FGZ3oUWF9jJiWvmDDk-2fWC3QmhZPst4Jsl0TuG2F4xZ38AxTP8mPGXhZrjMOYN6Ps_FOWgtD68zVky5a8VubNPISyzPiyixTW4mlFxAc4ugy62tTThUz5aW5Dq5gnr5uRTX6G9LfqMW6hdnr4Qc
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaPix2LM3ha3sdLxQEzoJKgwENHwRtatC9NkEDc08td7bUB84q1pm0vb9O76cff7AdyYEXdoTIlhV2NqSEAlo27bsVETAY8cQoSIVYCsX2u_Oo8jMirA-yoXRuGEfitwRNSoEPU9V_Z6tn7E8lRsZXbLE6ya3rWGDU9f3Y6phaZY95qN-37P6zGdsQbzdX-AZ12zSiStBNuCbSrReeXR6a0ps1Jm_11Kax92-igtzQ-gsJiUocRWzGtl2O0uP7yxuNS97BDqz_MkDRaSZEdoEW6cL4XZnWlBpr0MmJb_oMOTbR_YLRNakk4SnkgynSO4bt0PWdvAMYz_Jjxm_nq4rHoMxXSaihPQai5eZ6yQcscKndCmgRtZrhtQYpvcjCg5hcoGQWcbW6-g1B52O-POg_9UgT31hGlJ3pNzKOafc3GBvjfnl2rRfgG99YcJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Quinazoline+derivatives+as+SRC+tyrosine+kinase+inhibitors&rft.inventor=PLE+PATRICK&rft.date=2007-12-12&rft.externalDBID=C&rft.externalDocID=CN100354278CC